How FDA Classification Determines Your Cap Table
Not regulatory training — structural consequence analysis. How 510(k) vs. PMA vs. IND-to-NDA pathways determine capital requirements, funding round count, dilution trajectory, and founder equity at exit. How acquirers price regulatory risk into deal terms.